Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a newer site version but does not imply changes to the study details presented on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small update to the page's documentation or template.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page's revision tag updated from v3.6.2 to v3.6.3, signaling a small update to the page rather than a change to the study information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a version update to the page content. This likely reflects minor edits or updates to the page's metadata or formatting.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows updated recruitment messaging (No longer looking for participants). A heading label change from 'Intervention / Treatment' to 'Intervention/Treatment' and an updated site revision tag (Revision: v3.6.0) are also present.SummaryDifference0.4%

- Check70 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5. This reflects a new version of the page and does not appear to change study data or visible content.SummaryDifference0.0%

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.